# Top 50 Life Science VC (Venture Capital) Funds in Asia in June 2026 ## Prox Ventures - Type: VC Fund - Location: Shanghai, Shanghai, China - Relevant deals: 9 - Stages: Seed, Series A - Focus: Medical, Biotechnology, Health Care Proxima Ventures focuses in the healthcare industry, supporting outstanding enterprises with innovative technologies or service models that have tremendous potential.They manage multiple funds in RMB and US dollar, covering from seed to growth stages. Their team members with multidisciplinary backgrounds and resourceful networks, have many yearsof remarkable venture capital experience and achievements. They believe that active and effective collaboration with entrepreneurs will make substantial economic returns while bring meaningful improvements in public health. ## Mitsubishi UFJ Capital - Type: VC Fund - Location: Tokyo, Tokyo, Japan - Relevant deals: 6 - Stages: Series A, Series B - Focus: Information Technology, Software, Health Care Mitsubishi UFJ Capital is a venture capital firm focusing on life science, ICT, and high technology investments. ## Hillhouse Investment - Type: VC Fund - Location: Changyang, Beijing, China - Relevant deals: 6 - Stages: Series B, Series A, Series C - Focus: Biotechnology, Health Care, Software Founded in 2005, Hillhouse is a leading global investment management firm, active across public equity, private equity, real estate and private credit. The firm invests over a long-term horizon and partners with exceptional entrepreneurs to deliver sustainable value creation for quality companies.Hillhouse is a full life-cycle private equityfirm, investing for the long term across opportunities in the healthcare, business services, consumer, and industrials sectors. The firm manages capital on behalf of global institutions such as non-profit foundations, endowments, and pensions. ## Qiming Venture Partners - Type: VC Fund - Location: Shanghai, Shanghai, China - Relevant deals: 6 - Stages: Series B, Series A, Series C - Focus: Health Care, Biotechnology, Medical Founded in 2006, Qiming Venture Partners is a leading China venture capital firm with offices in Shanghai, Beijing, Suzhou, Hong Kong in China, and Singapore.Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.5 billion in capital raised. Since our establishment, we have invested in outstanding companiesin the Technology and Consumer (T&C) and Healthcare industries at the early and growth stages.Since our debut, we have backed over 530 fast-growing and innovative companies. Over 200 of our portfolio companies have achieved exits through IPOs at the NYSE, NASDAQ, HKEX, Shanghai Stock Exchange, or Shenzhen Stock Exchange, or through M&A or other means. There are also over 70 portfolio companies that have achieved unicorn or super unicorn status. ## HSG - Type: VC Fund - Location: Beijing, Beijing, China - Relevant deals: 5 - Stages: Series A, Series B, Series C - Focus: Health Care, Biotechnology, Software We help founders build enduring companies. ## SMBC Venture Capital - Type: VC Fund - Location: Tokyo, Tokyo, Japan - Relevant deals: 5 - Stages: Series A, Series B - Focus: Information Technology, Health Care, Software Sumitomo Mitsui Banking Corporation (SMBC) and its group companies offer a broad range of financial services centered on banking. They are also engaged in the leasing, securities, credit card, investment, mortgage securitization, venture capital and other credit related businesses. The following lists the activities of SMBC, its subsidiaries andaffiliates in the various business segments. ## Linear Capital - Type: VC Fund - Location: Shanghai, Shanghai, China - Relevant deals: 5 - Stages: Seed, Angel, Series A - Focus: Artificial Intelligence, Software, Manufacturing Linear Capital is a Frontier Tech Fund founded in 2014 by Harry Wang, Facebook's first Chinese R&D manager. We currently manage 10 funds with AUM of more than $2 billion. ## Baidu Ventures - Type: VC Fund - Location: Beijing, Beijing, China - Relevant deals: 4 - Stages: Series A, Seed, Series B - Focus: Artificial Intelligence, Health Care, Biotechnology Doma Protocol is a purpose-built blockchain to modernize and unlock the liquidity of over 362M existing and future domains ## Miyako Capital - Type: VC Fund - Location: Kyoto, Kyoto, Japan - Relevant deals: 4 - Stages: Series A, Seed, Series B - Focus: Medical, Biotechnology, Information Technology Miyako Capital is the venture capital that manages Kyoto University 2nd Venture Fund (KUVF). The company was founded in 2013 and based in Kyoto & Tokyo, Japan. Investment fields are: 1) Life Science, Biotechnology: Drug creation, regenerative medicine, medical beauty equipment, medical services.2) Agri-Food: Industrialization,agricultural and fishery products growth-promoting technology, specified health food, health food.3) Environment, Energy: Alternative energy, and related technologies.4) IT, Electronics: Web, mobile related devices and application, telecommunication technology, security, consumer and business oriented application, mechatronic, robot.5) New services utilizing state-of-art technology.Investment stages: Primary investment stages are initial-growth stages of seed and early. However, we aim at all growth stages and make investment in post-IPO portfolio companies as well as public companies that are related with Kyoto University. ## EFung Capital - Type: VC Fund - Location: Shenzhen, Guangdong, China - Relevant deals: 4 - Stages: Series A, Series B, Series C - Focus: Health Care, Biotechnology, Medical Shenzhen EFUNG Investment Management Enterprise L. P. is one of China's earliest institutions investing in professional biomedical industries. Their strong research team and great investment returns made us won 'The Most Pioneering VC Institution” 'The Most Dynamic Pharmaceutical VC Institution in China' and 'The Top Ten VCInstitutions in Shenzhen'. With this influence, EFUNG has drawn a lot of attention from the medical and life science industry. And it is interviewed by Nature, which is the most authoritative science magazine in the world. Over a decade of years, they have been focusing on the medical and health industry, especially the VC and PE investment business of novel drugs and high-end medical devices. The mission of EFUNG is to drive the industrialization of medical researches by capital and to gain rich returns to investors. EFUNG has deeply screened and invested in more than 20 domestic and international premium enterprises, such as Chipscreen Biosciences, Frontier Biotechnologies, Ascentage Pharma, Lifotronic, Aridis Pharmaceuticals, and Centrexion. ## Osaka University Venture Capital - Type: VC Fund - Location: Osaka, Osaka, Japan - Relevant deals: 4 - Stages: Seed, Series A - Focus: Biotechnology, Health Care, Manufacturing Osaka University Venture Capital is a venture capital firm that focuses on early-stage ventures in the fields of life innovation, green innovation, and platform technology. The firm was founded in 2014 and based in Osaka, Japan. ## UntroD Capital - Type: VC Fund - Location: Sumida, Tokyo, Japan - Relevant deals: 4 - Stages: Seed, Series A - Focus: Manufacturing, Biotechnology, Medical UntroD Capital is an R&D-based innovative technology that specializes in social implementation. ## Nissay Capital - Type: VC Fund - Location: Tokyo, Tokyo, Japan - Relevant deals: 4 - Stages: Seed, Series A - Focus: Health Care, Information Technology, Medical Nissay Capital is a venture capital Company specializing in seed, start-up, growth capital, middle stage, and later stage investment. ## Huagai Capital - Type: VC Fund - Location: Beijing, Beijing, China - Relevant deals: 4 - Stages: Series A, Series B, Angel - Focus: Health Care, Biotechnology, Medical Huagai Capital is a private equity investment firm that invests in start-up or growth companies in the areas of healthcare, TMT, and culture. ## MiraclePlus - Type: VC Fund - Location: Haidian, Beijing, China - Relevant deals: 3 - Stages: Seed, Angel, Pre-Seed - Focus: Artificial Intelligence, Software, Information Technology MiraclePlus invests in and accelerates early-stage startups. MiraclePlus assists startups in developing products that are good enough to succeed in the market. MiraclePlus' acceleration program works with the founders to get each team in top shape so that they can present to thousands of investors on Demo Day. ## Anzu Partners - Type: VC Fund - Location: Washington, District of Columbia, United States - Relevant deals: 3 - Stages: Series A, Series B - Focus: Biotechnology, Software, Manufacturing Anzu Partners is an investment firm that focuses on industrial and life science technology companies with the potential to transform their industry. Anzu's portfolio support platform is dedicated to drive results beyond our initial investment and establish long-term relationships. We team with entrepreneurs to develop and commercializetechnological innovations by providing capital and deep expertise in business development, market positioning, global connectivity, and operations. .Co-founders Whitney Haring-Smith, David Michael, and David Seldin launched the firm in 2014 in Washington, District of Columbia. ## Northern Light Venture Capital - Type: VC Fund - Location: Beijing, Beijing, China - Relevant deals: 3 - Stages: Series A, Series B, Seed - Focus: Health Care, Medical, Biotechnology Supporting the next generation of entpreneurs in enterprise, healthcare, and consumer with disruptive potential. ## BioVenture - Type: VC Fund - Location: Suzhou, Jiangsu, China - Relevant deals: 3 - Stages: Series A, Series B, Seed - Focus: Health Care, Medical, Biotechnology Suzhou Industrial Park Bioventure Investment Management Limited (Bioventure) was established in September 2013. Bioventure its first element of the new bio-industry funds 540 million yuan fund size. Bioventure specialize in the field of life sciences in the early stages of the venture capital investments as having high strength and growth, greaterdevelopment space, excellent management team, biotechnology, drug discovery, medical devices and healthcare services companies, and provide capital, management , operation and other aspects of post-investment support and services.Bioventure brought together senior investment professionals team with bio-pharmaceutical industry investment experience, strong fund management, entrepreneurship and venture capital and operating experience in business, have a deep understanding of the domestic and foreign markets, capable of its forward-looking international perspective and extensive The industry has the potential resources to help innovative companies grow rapidly and gain greater success, while giving fund investors bring considerable returns.Suzhou Industrial Park, the core investor BioBay has the country's best medical and pharmaceutical incubator function, use the platform, the project team has great resources and industrial service advantages, Yuan-sheng venture has successfully invested in 20 projects have been cast projects in their own development and follow-up financing, has made outstanding achievements in the industry for all to see, and won the Venture's trust and praise.By focusing and extensive industry resources, Bioventure determined to become one of China's most successful medical and pharmaceutical venture fund. Bioventure expectations and in the medical and pharmaceutical industry where there joint venture development cooperation. ## Legend Capital - Type: VC Fund - Location: Beijing, Beijing, China - Relevant deals: 3 - Stages: Series B, Series A, Series C - Focus: Health Care, Medical, Biotechnology Legend Capital, a subsidiary of Legend Holdings Ltd., started its vintage year in April, 2001 with a mission to become a top-notch and the most respected venture capital investment manager in China.Managing up to US$700 million across four funds, Legend Capital focuses on driving high-growth ventures with operations substantially based in Chinaor on markets related to China.Legend Capital mainly invests in early stage IT companies, specifically, in sectors of network applications and services, outsourcing and professional services, Infrastructure (IC design/key components), and mid-market growth stage companies in the fields of consumer goods, clean technology, health care, equipment manufacturing and modern services.Among over 60 portfolio companies are Joyo.com (acquired by Amazon.com), SinoCom (0299.HK), Solarfun Power (Nasdaq: SOLF), Spreadtrum Communications (Nasdaq: SPRD), China Sunshine Paper (2002.HK), and VanceInfo (NYSE:VIT), Eyang (0117.HK), etc.As an active investor, Legend Capital provides its portfolio companies extensive business resources and tailored services to assist with business development, company image building, and other critical company building activities on Chinese market so as to add value and maximize returns. Legend Capital is proud and thankful that it has the opportunity to blaze a trail with its innovative practice for China's venture capital industry. ## Angel Bridge - Type: VC Fund - Location: Tokyo, Tokyo, Japan - Relevant deals: 3 - Stages: Series A, Seed - Focus: Information Technology, Software, Consulting Angel Bridge is a angel investor groups in Japan and provide high quality and abundant funds to excellent companies. ## DG Daiwa Ventures - Type: VC Fund - Location: Marunouchi, Tokyo, Japan - Relevant deals: 3 - Stages: Seed, Series A - Focus: FinTech, Software, Internet DG Daiwa Ventures invests in start-up companies with next-generation technology and provides business development support. It is focused on blockchain, xR, AI, security, and BioHealth, as they are likely to be at the foundations of future businesses. In addition to the five core technologies, the fund will also focus on IoT technologies, whichoften overlap or serve as an application layer. ## CITIC Capital Holdings - Type: VC Fund - Location: Central, Hong Kong Island, Hong Kong - Relevant deals: 3 - Stages: Series A, Series B, Series C - Focus: Manufacturing, Health Care, E-Commerce CITIC Capital Holdings is an alternative investment management and advisory company headquartered in China. ## Entrepreneurship Relay Group - Type: VC Fund - Location: Yangpu, Hainan, China - Relevant deals: 3 - Stages: Series A, Angel - Focus: Manufacturing, Software, Enterprise Entrepreneurship Relay Group manages a fund of more than 4 billion yuan, directly or indirectly. ## ASBV - Type: VC Fund - Location: Shenzhen, Guangdong, China - Relevant deals: 3 - Stages: Seed, Series A, Angel - Focus: Health Care, Medical, Biotechnology ASBV focuses on early and mid-term venture capital investments. ## Keio Innovation Initiative - Type: VC Fund - Location: Tokyo, Tokyo, Japan - Relevant deals: 3 - Stages: Series A, Seed - Focus: Medical, Health Care, Biotechnology Keio Innovation Initiative (KII) is a venture capital established by Keio University. In order to make more effective use of the research results of Keio University, we aim to contribute to the development of society by creating investment for venture companies that utilize research results and creating new industries.The key to thinking aboutJapan's future growth strategy is to utilize advanced research results of the university. In addition to GDP, in addition to GDP, Japan is the world's third largest R & D exporter in R & D expenses, but as the low growth rate shows, it has a problem in investment efficiency in research and development. There are also reports on the entrepreneurial spirit that is indispensable for creating new industries, with the lowest entrepreneurial activity rate among developed countries. ## Senshu Ikeda Capital - Type: VC Fund - Location: Osaka, Osaka, Japan - Relevant deals: 3 - Stages: Series A, Seed - Focus: Software, Manufacturing, Internet Senshu Ikeda Capital offers financial consultancy services. ## WuXi AppTec - Type: VC Fund - Location: Shanghai, Shanghai, China - Relevant deals: 3 - Stages: Series A, Series B, Series C - Focus: Biotechnology, Pharmaceutical, Health Care WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical, biotech and medical device industries worldwide to advance discoveries and deliver groundbreaking treatments to patients. As an innovation-driven and customer-focused company, WuXi AppTec helps our partners improve theproductivity of advancing healthcare products through cost-effective and efficient solutions,With industry-leading capabilities such as R&D and manufacturing for small molecule drugs, cell and gene therapies, and testing for medical devices, WuXi AppTec's open-access platform is enabling more than 3,900 collaborators from over 30 countries to improve the health of those in need – and to realize our vision that "every drug can be made and every disease can be treated". ## Vinno Capital - Type: VC Fund - Location: Shenzhen, Guangdong, China - Relevant deals: 3 - Stages: Series A, Seed, Series B - Focus: Manufacturing, Semiconductor, Hardware Vinno Capital focuses on early-stage venture investments in ICT and healthcare-related fields. ## CD Capital - Type: VC Fund - Location: Shanghai, Shanghai, China - Relevant deals: 3 - Stages: Series A, Series B, Seed - Focus: Health Care, Biotechnology, Medical Device CD Capital is a venture capital firm specialized in life sciences and medical technology. They are currently managing both RMB and USD funds with total size of $600M. CD Capital is operated by a professional team with diversified and profound industry backgrounds. They have made over 40 investments with high growth potential and earned a reputationas a premier venture capital firm with main focus on China healthcare industry. With broad network around China and the world, they have been able to seize the global trend, capture investment opportunities as well as help to define the future for China healthcare industry. Ultimately, they strive to grow best-in-class companies and deliver solid financial return to their investors. ## SBI Investment - Type: VC Fund - Location: Minato, Chiba, Japan - Relevant deals: 3 - Stages: Series B, Series A - Focus: Software, Information Technology, Financial Services SBI Investment supports the business development and growth of private venture companies through fund investment. It manages and manages venture capital funds under the management philosophy of becoming a leading company responsible for the creation and development of core industries in the 21st century as a "new industry creator".SBIInvestment has invested in a total of 986 companies in the past, of which 169 (17.1% of investment companies) have exited through IPO or M & A. ## Mizuho Capital - Type: VC Fund - Location: Tokyo, Tokyo, Japan - Relevant deals: 3 - Stages: Series A, Series B - Focus: Information Technology, Software, Internet Mizuho is the venture capital firm affiliated to Mizuho Bank, the second-largest Japanese bank in terms of assets. The firm has headquarters in Tokyo.The firm has ¥49.6 billion JPY under management, focusing on information technology and biotechnology investments. Over 600 Mizuho companies have gone public. According to Nikkei, Mizuho is thefifth-largest venture capital firm in Japan.Mizuho Capital was formed in 2002 by the merger of Fujigin Capital, Tokyo Venture Capital and IBJ Investment. Three firms were subsidiaries of Fuji Bank, Dai-Ichi Kangyo Bank and the Industrial Bank of Japan respectively. ## JAFCO - Type: VC Fund - Location: Tokyo, Tokyo, Japan - Relevant deals: 3 - Stages: Series A, Series B - Focus: Information Technology, Software, Artificial Intelligence Since its founding in 1973, JAFCO has always worked with leading-edge entrepreneurs. The total capital commitments of its investment funds in Japan and overseas have exceeded 1 trillion yen and the number of portfolio IPOs to date has reached over 1,000. In addition to venture investment, JAFCO also carries out buyout investment and commit to thecreations of innovative technologies and services worldwide. As entrepreneurs’ closest partner in bringing their visions to life, JAFCO provides support in areas of HR, marketing/ sales, and back-office operations, in addition to providing financing. ## ZSVC - Type: VC Fund - Location: Beijing, Beijing, China - Relevant deals: 3 - Stages: Series A, Seed, Series B - Focus: Manufacturing, Medical, Health Care ZSVC is a Chinese venture capital firm specialized in seed and early stage investments. ## Nippon Venture Capital - Type: VC Fund - Location: Tokyo, Tokyo, Japan - Relevant deals: 3 - Stages: Series A, Series B - Focus: Software, Health Care, Medical Nippon Venture Capital ("NVCC"), established in 1996 as one of the few largest Japanese independent venture capital firms, is destined to undertake the unprecedented task of providing full-range venture capital services in cooperation with major Japanese business leaders and leading companies, which have supported and nurtured various newbusinesses on their own, as well as proactively developing new venture enterprises. ## Hillhouse Ventures - Type: VC Fund - Location: Singapore, Central Region, Singapore - Relevant deals: 3 - Stages: Series A, Series B, Seed - Focus: Manufacturing, Biotechnology, Health Care Hillhouse Venture Capital is an investment institution established by Hillhouse Capital that focuses on investing in early-stage startups. ## Tianjin Venture Capital - Type: VC Fund - Location: Tianjin, Guangdong, China - Relevant deals: 3 - Stages: Seed, Series A - Focus: Manufacturing, Information Technology, Biotechnology Tianjin Venture Capital is an investment firm. ## ULTIMA - Type: VC Fund - Location: Chengdu, Sichuan, China - Relevant deals: 3 - Stages: Angel, Series A - Focus: Hardware, Software, Agriculture ULTIMA is an investment management firm. ## Bits x Bites - Type: VC Fund - Location: Shanghai, Shanghai, China - Relevant deals: 2 - Stages: Series A, Seed, Series B - Focus: Biotechnology, Food and Beverage, Food Processing Bits x Bites is a food tech VC that invests in early-stage startups tackling global food system challenges. It targets companies innovating across the food supply chain, from farming, production, distribution, and logistics, to consumer goods and food services. ## Sherpa Healthcare Partners - Type: VC Fund - Location: Beijing, Beijing, China - Relevant deals: 2 - Stages: Series A, Series B, Series C - Focus: Biotechnology, Health Care, Medical Sherpa Venture Capital is an investment firm that focuses on the investment and cultivation of the Pharmaceutical and Biotech industry. It also specializes in the investment and management of sector leaders and innovators within the Pharma, GeneTech, MedTech, Medical services, and various sub-sectors, where they have established robust portfoliosources, lasting value-adding cooperations and relationships, as well as mature all-cycle services with key resources. It was founded in 2018 and is headquartered in Beijing, China. ## Oriental Fortune Capital - Type: VC Fund - Location: Shenzhen, Guangdong, China - Relevant deals: 2 - Stages: Series A, Series B, Seed - Focus: Software, Manufacturing, Information Technology Shenzhen Oriental Fortune Capital Co Ltd. is a venture capital firm specializing investment in early venture, mid venture, late venture, emerging growth, Pre-IPO, mature, growth capital stage, mezzanine and new third board investments. The firm typically invests in financial services, telecommunication, new energy, consumer goods, medical treatmentand healthcare, life sciences, internet plus healthy lifestyle industry, logistics, energy technology, information technology, mobile innovation, media, movies and television, culture, pharmaceutical, biological medicine, renewable energy, retail, environmental protection business, consumption, new materials, new agriculture, advanced manufacturing, equipment manufacturing, culture, entertainment, and services. It seeks to invest in China focusing on Shenzhen, Shanghai, Beijing, Xi’an, and Wuhu. The firm also invests in Pearl River Delta region, Yangtze River Delta region, and Circum-Bohai-Sea region. For Pearl River Delta, it covers Guangzhou, Shenzhen, Foshan, Dongguan, Zhongshan, Zhuhai, Huizhou, Jiangmen, and Zhaoqing cities in China. For Yangtze River Delta, the firm covers Shanghai, Nanjing, Wuxi, Changzhou, Suzhou, Nantong, Yancheng, Yangzhou, Zhenjiang, Taizhou, Hangzhou, Ningbo, Jiaxing, Huzhou, Shaoxing, Jinhua, Zhoushan, Taizhou, Hefei, Wuhu, Ma’anshan, Tongling, Anqing, Chuzhou, Chizhou, and Xuancheng cities in China. For the Circum-Bohai-Sea region, it covers Beijing, Tianjin, Shenyang, Dalian, Qingdao, Dandong, Yingkou, Panjin, Fuxin, Huludao, Chaoyang, Shijiazhuang, Baoding, Tangshan, Qinhuangdao, Cangzhou, Langfang, Chengde, Zhangjiakou, Handan, Xingtai, Dongying, Yantai, Weifang, Weihai, Rizhao, and Binzhou cities in China. The firm prefers to invest 20% of its portfolio to early stage, 40% to expansion stage, and 40% to Pre-IPO stage. Shenzhen Oriental Fortune Capital Co Ltd. was formed in November 2007 and is based in Shenzhen, China with offices in Shanghai, China; Beijing, China; and Wuhu, China. ## Puhua Capital - Type: VC Fund - Location: Hangzhou, Zhejiang, China - Relevant deals: 2 - Stages: Series A, Series B, Seed - Focus: Health Care, Medical, Manufacturing Puhua Capital is an equity investment firm that focuses on early and middle project. Puhua Capital provides the required resources and management experience for the invested enterprise, investing funds and more resources and wisdom. Puhua Capital has invested nearly 300 excellent start-ups. ## CentreGold Capital - Type: VC Fund - Location: Fremont, California, United States - Relevant deals: 2 - Stages: Seed, Series A, Angel - Focus: Medical Device, Internet, Health Care Our team invests in early-stage digital health and consumer startups at CentreGold Capital. ## Gaw Capital Partners - Type: VC Fund - Location: Hong Kong, Hong Kong Island, Hong Kong - Relevant deals: 2 - Stages: Series A, Series C, Seed - Focus: Real Estate, Property Management, Hospitality Gaw Capital Partners is a positioned private equity fund management company that focuses in real estate markets in greater China and other high barrier-to-entry markets globally. Their services includes gateway real estate funds, separate account investments, venture capital, private equity investment and credit investments. ## Haitang Fund - Type: VC Fund - Location: Nankai, Tianjin, China - Relevant deals: 2 - Stages: Seed, Series A - Focus: Manufacturing, Biotechnology, Medical Haitang Fund is a venture capital fund jointly established by Tianjin University alumni entrepreneurs and other alumni and entrepreneurs. ## UTEC - The University of Tokyo Edge Capital Partners - Type: VC Fund - Location: Tokyo, Tokyo, Japan - Relevant deals: 2 - Stages: Seed, Series A - Focus: Health Care, Biotechnology, Medical UTEC-The University of Tokyo Edge Capital Partners Co., Ltd.. UTEC is a seed/early stage technology focused venture capital firm associated with The University of Tokyo. ## Huimei Capital - Type: VC Fund - Location: Beijing, Beijing, China - Relevant deals: 2 - Stages: Series A, Series B, Series C - Focus: Biotechnology, Health Care, Medical Huimei Capital primarily seeks investment in the medical and healthcare ecosystem in a multi-dimensional and three-dimensional manner. It is committed to building a professional investment platform with international vision and local execution, helping early and growing medical and health companies to grow rapidly. ## Shunwei Capital - Type: VC Fund - Location: Beijing, Beijing, China - Relevant deals: 2 - Stages: Series A, Series B, Series C - Focus: Manufacturing, Software, Internet Shunwei Capital is a venture capital fund that focuses on early to mid-stage investments in local internet industry. It specializes in incubation, startups, early to mid-stage, and growth capital investments. It seeks to invest in the technology, media, telecommunications, high technology, new media, games, internet finance, and rural area internetsectors. Their investors include sovereign wealth funds, fund of funds, university endowment funds, and family offices. ## BOHE Angel Fund - Type: VC Fund - Location: Suzhou, Jiangsu, China - Relevant deals: 2 - Stages: Angel, Series A, Seed - Focus: Health Care, Medical, Biotechnology BOHE Angel Fund is an investment Fund. ## Alibaba Entrepreneurs Fund - Type: VC Fund - Location: Causeway Bay, Hong Kong Island, Hong Kong - Relevant deals: 2 - Stages: Series A, Seed, Series B - Focus: Software, E-Commerce, Artificial Intelligence The Entrepreneurs Fund is a not-for-profit initiative launched by Alibaba Group in 2015 to help entrepreneurs and young graduates realize their dreams and vision. Two separate funds have been set up in Hong Kong and Taiwan respectively to support specific programs in each place. ## Eisai - Type: VC Fund - Location: Tokyo, Tokyo, Japan - Relevant deals: 2 - Stages: Series A, Series C - Focus: Biotechnology, Health Care, Medical Eisai is a pharmaceutical company that researches and delivers medicines for patients. # About Shizune Shizune.co is an investor database. Core features: - 48,091 startup investors (angels, VCs, accelerators, and others) - Email, phone, LinkedIn (for intros), socials, and other contact data - Updated daily from public funding news - CSV and Excel export The User can access the full database FOR FREE after signing up: shizune.co